XNAS
CELH
Market cap7.80bUSD
Jul 09, Last price
30.52USD
1D
-0.26%
1Q
-12.45%
Jan 2017
3,637.13%
IPO
4,547.69%
Name
Celsius Holdings Inc
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Celsius Holdings, Inc. is a global enterprise specializing in the development, production, promotion, and distribution of functional beverages and liquid nutritional supplements. Its extensive reach covers North America, Europe, Asia, and other international markets. The company's diverse product lineup includes CELSIUS Originals, offering both sparkling and still functional energy drinks. For a dietary supplement with an energy boost, they provide CELSIUS HEAT, available in carbonated varieties like apple jack'd, orangesicle, and inferno punch, as well as cherry lime, blueberry pomegranate, strawberry dragon fruit, tangerine grapefruit, and jackfruit. Muscle recovery is addressed with CELSIUS BCCA+ENERGY, a functional energy drink rich in branched-chain amino acids. Consumers seeking on-the-go options can find CELSIUS On-the-Go, which packages the active ingredients of their energy drinks as a powder in individual packets and canisters. Additionally, their CELSIUS Sweetened line features non-carbonated functional energy drinks in flavors such as sparkling grapefruit, cucumber lime, orange pomegranate, pineapple coconut, watermelon berry, and strawberries and cream. Celsius Holdings ensures its products reach a broad audience through a multifaceted distribution strategy, encompassing direct-to-store delivery partnerships, direct sales to various retailers including supermarkets, convenience stores, pharmacies, nutritional stores, and mass merchants, as well as sales to health clubs, spas, gyms, the military, and e-commerce channels. Founded in 2004 as Vector Ventures, Inc. before adopting its current name in January 2007, the company's headquarters are located in Boca Raton, Florida.
IPO date
Oct 10, 2006
Employees
378
Domiciled in
US
Incorporated in
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||